THE pulmonary circulation is of paramount importance in failure of the heart. The presence of dyspnea, orthopnea and hemoptysis and a diminution in vital capacity imply a profound change in the blood ...

"ACC 2026: Sotatercept shows signal in CpcPH-HFpEF at lower dose" was originally created and published by Pharmaceutical ...

Lung disease is a general term for several disorders that include airway diseases, lung tissue diseases, and lung circulation diseases, some of which may lead to respiratory failure. During the course ...

What Is Pulmonary Vascular Disease? The definition of pulmonary vascular disease is simple: any condition that affects the blood vessels along the route between the heart and lungs. Blood travels from ...

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary ...

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, today announced the publication of ...

Objectives Pulmonary diseases (PDs) in SLE are thought to be common and of clinical importance but can be difficult to ...

Nitric oxide (NO) is a key mediator of neural and haemodynamic effects. NO diffuses into vascular smooth muscle cells, stimulating the production of cGMP and leading to vasodilatation. The effects of ...

- Data presented show maintained or improved responses in multiple efficacy endpoints among patients treated with sotatercept plus stable background therapy for up to 48 weeks - - Patients receiving ...